The Effects of Sevoflurane and Desflurane on QT Interval Measured With Cardiac Electrophysiological Balance Index

February 2, 2022 updated by: Işıl Karabeyoğlu, Ankara City Hospital Bilkent

A Prospective Randomized Comparison of the Effects of Sevoflurane and Desflurane Anesthesia on QT Interval Measured With Cardiac Electrophysiological Balance Index

The primary aim of this study is to compare the effects of sevoflurane and desflurane on the QT interval. The secondary aim of this study is to compare the effects of drugs used in the induction and maintenance of anesthesia on the QT interval by calculating the Bazzet formula and iCEB.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. ASA I-II-III risk group
  2. the operation time is longer than 1 hour in the Urology department.

Exclusion Criteria:

  1. bundle branch block in preoperative ECG,
  2. Non-sinus heart rhythm,
  3. QT length in preoperative ECG,
  4. using drugs that cause known QT prolongation ( beta-blocker drugs using will be included),
  5. development of malignant arrhythmia that will disrupt hemodynamics in the intraoperative period,
  6. patients with electrolyte disorders,
  7. patient refusal -

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: sevoflurane
General Anesthesia procedure with sevoflurane
6 precordial and 4 extremity electrodes will be placed at appropriate anatomical points and a total of 6 12-lead ECGs will be taken at different anesthesia depths before anesthesia induction and throughout the operation.
Active Comparator: desflurane
General Anesthesia procedure with desflurane
6 precordial and 4 extremity electrodes will be placed at appropriate anatomical points and a total of 6 12-lead ECGs will be taken at different anesthesia depths before anesthesia induction and throughout the operation.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
QTc T0
Time Frame: Baseline, preoperative
QTc; It is calculated by dividing the QT interval by the square root of the RR interval (QTc= QT/ √RR).
Baseline, preoperative
QTc T1
Time Frame: During surgery (at the time of the anesthesia induction)
QTc; It is calculated by dividing the QT interval by the square root of the RR interval (QTc= QT/ √RR).
During surgery (at the time of the anesthesia induction)
QTc T2
Time Frame: During surgery (at the time of MAC reached 0,6)
QTc; It is calculated by dividing the QT interval by the square root of the RR interval (QTc= QT/ √RR).When the mac value reaches 0,6, it will be calculated from the ECG.
During surgery (at the time of MAC reached 0,6)
QTc T3
Time Frame: During surgery (at the time of MAC reached1)
QTc; It is calculated by dividing the QT interval by the square root of the RR interval (QTc= QT/ √RR).When the mac value reaches 1, it will be calculated from the ECG.
During surgery (at the time of MAC reached1)
QTc T4
Time Frame: During surgery (at the time of MAC reached 1,3)
QTc; It is calculated by dividing the QT interval by the square root of the RR interval (QTc= QT/ √RR).When the mac value reaches 1,3 , it will be calculated from the ECG.
During surgery (at the time of MAC reached 1,3)
QTc T5
Time Frame: During surgery (at the time of MAC reduced 0,3)
QTc; It is calculated by dividing the QT interval by the square root of the RR interval (QTc= QT/ √RR).When the mac value reduces 0,3, it will be calculated from the ECG.
During surgery (at the time of MAC reduced 0,3)
iCEB T0
Time Frame: Baseline, preoperative
Index of cardio-electrophysiological balance (iCEB); calculated as QT distance divided by QRS duration (QT/ QRS)
Baseline, preoperative
iCEB T1
Time Frame: During surgery (at the time of the anesthesia induction)
Index of cardio-electrophysiological balance (iCEB); calculated as QT distance divided by QRS duration (QT/ QRS)
During surgery (at the time of the anesthesia induction)
iCEB T2
Time Frame: During surgery (at the time of MAC reached 0,6)
Index of cardio-electrophysiological balance (iCEB); calculated as QT distance divided by QRS duration (QT/ QRS) the mac value reaches 0,6, it will be calculated from the ECG.
During surgery (at the time of MAC reached 0,6)
iCEB T3
Time Frame: During surgery (at the time of MAC reached 1)
Index of cardio-electrophysiological balance (iCEB); calculated as QT distance divided by QRS duration (QT/ QRS) the mac value reaches 1, it will be calculated from the ECG.
During surgery (at the time of MAC reached 1)
iCEB T4
Time Frame: During surgery (at the time of MAC reached 1,3)
Index of cardio-electrophysiological balance (iCEB); calculated as QT distance divided by QRS duration (QT/ QRS) the mac value reaches 1,3, it will be calculated from the ECG.
During surgery (at the time of MAC reached 1,3)
iCEB T5
Time Frame: During surgery (at the time of MAC reduced 0,3)
Index of cardio-electrophysiological balance (iCEB); calculated as QT distance divided by QRS duration (QT/ QRS) when the mac value reduces 0,3, it will be calculated from the ECG.
During surgery (at the time of MAC reduced 0,3)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: ışıl karabeyoğlu, Ankara CH bilkent
  • Study Chair: betül güven aytaç, Ankara CH bilkent

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

February 1, 2022

Primary Completion (Anticipated)

May 1, 2022

Study Completion (Anticipated)

July 1, 2022

Study Registration Dates

First Submitted

January 5, 2022

First Submitted That Met QC Criteria

February 2, 2022

First Posted (Actual)

February 7, 2022

Study Record Updates

Last Update Posted (Actual)

February 7, 2022

Last Update Submitted That Met QC Criteria

February 2, 2022

Last Verified

February 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • E1-21-2256

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sevoflurane

Clinical Trials on 12- derivation Electrocardiography

Subscribe